Literature DB >> 23681884

Bone protection in chronic obstructive pulmonary disease (COPD) patients requiring regular intermittent glucocorticoid therapy.

Kavitha Nadesalingam, David Kirby.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 23681884      PMCID： PMC4952652          DOI： 10.7861/clinmedicine.13-2-216

Source DB:  PubMed          Journal:  Clin Med (Lond)        ISSN： 1470-2118            Impact factor:   2.659


× No keyword cloud information.
  3 in total

1.  Fracture risk associated with different types of oral corticosteroids and effect of termination of corticosteroids on the risk of fractures.

Authors:  Peter Vestergaard; Lars Rejnmark; Leif Mosekilde
Journal:  Calcif Tissue Int       Date:  2008-04-15       Impact factor: 4.333

2.  Bone mineral density and fractures in older men with chronic obstructive pulmonary disease or asthma.

Authors:  T-T Dam; S Harrison; H A Fink; J Ramsdell; E Barrett-Connor
Journal:  Osteoporos Int       Date:  2009-10-09       Impact factor: 4.507

Review 3.  Long-term therapy in COPD: any evidence of adverse effect on bone?

Authors:  Arnulf Langhammer; Siri Forsmo; Unni Syversen
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2009-10-19
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.